SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ABIOMED, Inc. – ‘8-K’ for 11/1/22 – ‘XML’

On:  Tuesday, 11/1/22, at 8:14am ET   ·   For:  11/1/22   ·   Accession #:  950170-22-20707   ·   File #:  1-09585

Previous ‘8-K’:  ‘8-K’ on 11/1/22 for 10/31/22   ·   Next & Latest:  ‘8-K’ on / for 12/22/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/01/22  ABIOMED, Inc.                     8-K:2,9    11/01/22   11:1.1M                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     64K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    900K 
 6: R1          Document and Entity Information                     HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- abmd-20221101_htm                   XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- abmd-20221101_lab                     XML     53K 
 5: EX-101.PRE  XBRL Presentations -- abmd-20221101_pre              XML     33K 
 4: EX-101.SCH  XBRL Schema -- abmd-20221101                         XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    18K 
11: ZIP         XBRL Zipped Folder -- 0000950170-22-020707-xbrl      Zip     51K 


‘XML’   —   XBRL Instance — abmd-20221101_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="abmd-20221101.xsd" xlink:type="simple"/>
<context id="C_95d35e76-c5b5-4362-8f75-99a14d388b71">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000815094 </identifier>
</entity>
<period>
<startDate> 2022-11-01 </startDate>
<endDate> 2022-11-01 </endDate>
</period>
</context>
<dei:EntityCentralIndexKey contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_abeb16c2-f48c-4071-91aa-8026d4f6bf17"> 0000815094 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_e92919b0-c69d-4d95-a572-acca816b211b"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_0d28eaac-91db-4012-a6b0-140f09200893"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_3c44b19c-2f35-4696-b524-ee4fd43c42a6"> 2022-11-01 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_b2869bec-cd18-4788-ac6f-ae20facd3b12"> ABIOMED, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_8c30c409-2cf3-4509-86b4-e68c08237aca"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_3e697fbf-d19c-46cc-929a-802af19bb325"> 001-09585 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_1e250b1b-c606-483e-b055-2e7529bcc1e1"> 04-2743260 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_42cddcef-db6f-4925-ac93-13f10331db81"> 22 Cherry Hill Drive </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_c22b4b33-eba5-4b0d-bc10-09a497574edd"> Danvers </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_e6de0593-a6c8-4592-af59-1a1c327a1812"> MA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_f70ae315-8cc1-4ec8-a3cc-3d6ac045ef9f"> 01923 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_aa44aac4-6fc3-4cd4-a6cd-d53d85143d62"> 978 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_c70732bf-d237-4f44-ba7d-9b73205e8472"> 646-1400 </dei:LocalPhoneNumber>
<dei:Security12bTitle contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_0e918652-3f4a-4532-87e2-4b718fb16a0f"> Common Stock, $0.01 par value </dei:Security12bTitle>
<dei:TradingSymbol contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_131b1bd5-f55e-4abe-9268-ad715ea83970"> ABMD </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_c099bd47-b7fe-4a79-9dde-900f911487b0"> NASDAQ </dei:SecurityExchangeName>
<dei:WrittenCommunications contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_d9187cf2-251f-450c-bab1-f8240977ebad"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_5ef1b509-d1da-44ac-a51b-cef6be82988f"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_32cc0e6d-ae2a-48ea-b770-b3d56c1b3f9b"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_fb007d6f-bf8d-45b7-90c2-7907e02529d0"> false </dei:PreCommencementIssuerTenderOffer>
<dei:EntityEmergingGrowthCompany contextRef="C_95d35e76-c5b5-4362-8f75-99a14d388b71" id="F_a4738e15-43c5-4bba-ac3e-c271bf3607af"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

Top
Filing Submission 0000950170-22-020707   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 3:08:38.1pm ET